Erik Atkisson
Compliance Officer en RAIN ONCOLOGY INC. .
Fortuna: 1 001 $ al 31/03/2024
Perfil
Erik Atkisson is currently the General Counsel & Chief Compliance Officer at Rain Oncology, Inc. Prior to this, he was the Chief Compliance Officer at Cytokinetics, Inc. He also served as the Secretary & General Counsel at Eiger BioPharmaceuticals, Inc. from 2021 to 2023.
Mr. Atkisson received his undergraduate degree from Harvard University, his graduate degree from The University of Edinburgh, and his law degree from Georgetown University Law Center.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 26/01/2023 | 200 ( 0.01% ) | 1 001 $ | 31/03/2024 |
Cargos activos de Erik Atkisson
| Empresas | Cargo | Inicio |
|---|---|---|
| RAIN ONCOLOGY INC. | Compliance Officer | - |
Antiguos cargos conocidos de Erik Atkisson.
| Empresas | Cargo | Fin |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Compliance Officer | 13/04/2023 |
| CYTOKINETICS, INCORPORATED | Compliance Officer | - |
Formación de Erik Atkisson.
| Harvard University | Undergraduate Degree |
| The University of Edinburgh | Graduate Degree |
| Georgetown University Law Center | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Erik Atkisson
